ARKG ETF — Holdings & Market Internals
A visuals-first look inside ARK Genomic Revolution ETF (ARKG): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 32-name holdings snapshot.
Historical breadth is computed against the current ARKG membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 90% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 32.5 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 1.57% | +172.07% | 92 |
| TWST | Twist Bioscience Corporation Common Stock | 8.99% | +61.95% | 70 |
| TEM | Tempus AI, Inc. Class A Common Stock | 8.29% | +56.92% | 66 |
| GENB | Generate Biomedicines, Inc. Common Stock | 1.03% | +49.41% | 77 |
| MASS | 908 Devices Inc. Common Stock | 1.03% | +48.25% | 80 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 2.15% | +47.22% | 69 |
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
Holdings Explorer
Top 30 by weight — sort any column. View all 32 holdings →
| TXG | 10x Genomics, Inc. Class A Common Stock | Industrials | 9.72% | $64.87 | +1.44% | +39.63% | +169.44% | 71 | 99 | $6.0B |
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 8.99% | $151.55 | +7.69% | +61.95% | +148.07% | 70 | 100 | $6.3B |
| TEM | Tempus AI, Inc. Class A Common Stock | Technology | 8.29% | $68.39 | +3.88% | +56.92% | +45.99% | 66 | 38 | $8.3B |
| CRSP | CRISPR Therapeutics AG | Health Care | 6.17% | $60.38 | +6.63% | +27.78% | +20.17% | 66 | 67 | $4.7B |
| PSNL | Personalis, Inc. Common Stock | Health Care | 5.92% | $17.11 | +1.11% | +44.35% | +97.82% | 67 | 99 | $1.4B |
| ABSI | Absci Corporation Common Stock | Health Care | 4.97% | $9.67 | +9.05% | +23.38% | +84.48% | 56 | 99 | $1.3B |
| LLY | Eli Lilly & Co. | Health Care | 4.12% | $1232.13 | -1.06% | +2.72% | +14.76% | 55 | 93 | $1.02T |
| NTRA | Natera, Inc. Common Stock | Health Care | 4.06% | $339.50 | +2.74% | +27.62% | +63.87% | 72 | 96 | $38.7B |
| ILMN | Illumina Inc | Health Care | 4.00% | $225.50 | +0.80% | +15.77% | +55.58% | 72 | 97 | $31.0B |
| GH | Guardant Health, Inc. Common Stock | Health Care | 3.99% | $164.28 | +1.04% | +11.94% | +38.65% | 55 | 98 | $21.7B |
| CDNA | CareDx, Inc. | Health Care | 3.58% | $51.30 | +6.99% | +36.52% | +133.56% | 73 | 99 | $2.3B |
| BEAM | Beam Therapeutics Inc. Common Stock | Health Care | 3.41% | $31.03 | +9.55% | +21.93% | +6.49% | 61 | 95 | $2.6B |
| CMPS | COMPASS Pathways Plc American Depository Shares | Health Care | 3.21% | $14.84 | +4.82% | +32.15% | +21.27% | 64 | 99 | $1.5B |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | Health Care | 2.37% | $3.54 | +9.54% | +17.49% | +17.49% | 58 | 32 | $1.7B |
| NRIX | Nurix Therapeutics, Inc. Common stock | Health Care | 2.37% | $26.93 | +2.63% | +13.95% | +53.56% | 63 | 98 | $2.4B |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Health Care | 2.35% | $26.30 | +2.74% | +15.64% | +87.50% | 65 | 96 | $3.6B |
| BFLY | Butterfly Network, Inc. | Health Care | 2.28% | $9.07 | +1.12% | +35.13% | +99.12% | 56 | 100 | $1.9B |
| SDGR | Schrodinger, Inc. Common Stock | Health Care | 2.23% | $19.69 | +6.45% | +31.51% | +51.10% | 67 | 51 | $1.1B |
| WGS | GeneDx Holdings Corp. Class A Common Stock | Health Care | 2.15% | $85.84 | +2.59% | +47.22% | +81.75% | 69 | 32 | $2.0B |
| VCYT | Veracyte, Inc. | Health Care | 1.86% | $44.30 | +6.29% | -23.78% | -2.89% | 43 | 89 | $3.6B |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Health Care | 1.79% | $63.80 | +2.43% | +11.67% | -16.36% | 61 | 89 | $8.6B |
| NTLA | Intellia Therapeutics, Inc | Health Care | 1.73% | $13.46 | +7.64% | +22.93% | +6.63% | 59 | 83 | $1.5B |
| ALMR | Alamar Biosciences, Inc. Common Stock | Industrials | 1.73% | $32.95 | +0.89% | +25.79% | +64.77% | 59 | 0 | $2.4B |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Health Care | 1.57% | $15.25 | +7.74% | +172.07% | +116.55% | 92 | 37 | $164M |
| PRME | Prime Medicine, Inc. Common Stock | Health Care | 1.27% | $3.66 | +14.00% | +24.92% | +23.26% | 61 | 64 | $508M |
| CERS | Cerus Corp | Health Care | 1.09% | $2.74 | +1.12% | -8.11% | +0.00% | 49 | 97 | $433M |
| GENB | Generate Biomedicines, Inc. Common Stock | Health Care | 1.03% | $20.25 | +15.07% | +49.41% | +37.70% | 77 | 0 | $1.8B |
| MASS | 908 Devices Inc. Common Stock | Industrials | 1.03% | $11.00 | +0.78% | +48.25% | +49.66% | 80 | 94 | $345M |
| PACB | Pacific Biosciences of California, Inc. | Industrials | 0.68% | $1.50 | +18.75% | +11.76% | +22.58% | 61 | 74 | $441M |
| SCTX | Scribe Therapeutics Inc. Common Stock | Health Care | 0.64% | $32.75 | -16.08% | +45.27% | -- | 61 | 0 | -- |